Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS
Recruiting
- Conditions
- Pregnancy ComplicationsPolycystic Ovary Syndrome
- Interventions
- Other: Observation
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 180
- Registration Number
- NCT06545994
- Locations
- 🇨🇳
OB & GYN Hospital of Fudan University, Shanghai, Shanghai, China
Primary Tumor Resection for M1a Stage Lung Cancer
Recruiting
- Conditions
- Surgical ResectionLung Cancer Metastatic
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 66
- Registration Number
- NCT06547710
- Locations
- 🇨🇳
Fudan University Cancer Center, Shanghai, Shanghai, China
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
Not Applicable
Completed
- Conditions
- Rectal Cancer
- Interventions
- Behavioral: Physical exerciseDietary Supplement: Nutrition supplementBehavioral: Mental support
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 108
- Registration Number
- NCT06542354
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
Recruiting
- Conditions
- Thyroid Cancer
- Interventions
- Drug: RET InhibitorProcedure: Surgery
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 48
- Registration Number
- NCT06530316
- Locations
- 🇨🇳
Fudan Univeristy Shanghai Cancer Center, Shanghai, China
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Phase 2
Recruiting
- Conditions
- Microsatellite Stable Metastatic Colorectal Cancer
- Interventions
- Drug: standard systemic therapy combined with high/low-dose radiotherapy plus toripalimab
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 96
- Registration Number
- NCT06525428
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
Recruiting
- Conditions
- Thyroid Cancer
- Interventions
- Radiation: adjuvant radiotherapy
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT06524167
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Not yet recruiting
- Conditions
- Peripheral Arterial DiseasePerfusion
- Interventions
- Diagnostic Test: DCE MRI
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT06525415
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Phase 2
Recruiting
- Conditions
- Advanced Colorectal CarcinomaImmunotherapy
- Interventions
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 208
- Registration Number
- NCT06521866
- Locations
- 🇨🇳
Fujian Cancer Hospital, Fuzhou, Fujian, China
🇨🇳The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
🇨🇳Lanzhou Military Region General Hospital, Lanzhou, Gansu, China
Artificial Intelligence Assisted Breast Ultrasound in Breast Cancer Screening
Not Applicable
Completed
- Conditions
- Breast CancerScreening
- Interventions
- Device: Routine breast ultrasoundDevice: AI-assisted breast ultrasound
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 21790
- Registration Number
- NCT06521788
- Locations
- 🇨🇳
Maternal and Infant Healthy Centre of Hongkou District, Shanghai, Shanghai, Shanghai, China
🇨🇳Shanghai Pudong New Area Healthcare Hospital For Women & Children, Shanghai, China
🇨🇳Fudan University Shanghai Cancer Center, Shanghai, China
Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
Phase 2
Recruiting
- Conditions
- Relapsed/Refractory Peripheral T Cell Lymphoma
- Interventions
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 25
- Registration Number
- NCT06519526
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath